Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

GOSS Stock Forecast, Price Targets, Chart, Dividends & Analysis

Gossamer Bio Inc. logo

Gossamer Bio Inc.

Sector: Healthcare   

Industry: Biotechnology

0.84
 
USD
  
0.00
  
(-0.11%)
Previous close: 0.8409  Open: 0.83  Bid: 0.8103  Ask: 0.85
52 week range    
0.50   
   1.60
Mkt Cap: 198 M  Avg Vol (90 Days): 1,290,076
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Sunday 22nd December 2024

Stock Rankings

45
MarketXLS Rank
60
Value
46
Technical
31
Quality
How are these ranks calculated?
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0.0085

OTLC

OVAT-CA

Financials

GOSS Income Statement

Annual
Invalid dateDec-19Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-3.29-3.55-3.13-2.71-1.18
Basic EPS total-3.29-3.55-3.13-2.71-1.18
Basic weighted shares outstanding55 M69 M75 M85 M153 M
Depreciation900000.01 M2 M2 M2 M
DepreciationAndAmortization900000.01 M2 M2 M2 M
Diluted EPS total-3.29-3.55-3.13-2.71-1.18
Diluted normalized net income/share-3.13-2.71-1.18
Diluted weighted shares outstanding55 M69 M75 M85 M153 M
GeneralAndAdministrativeExpense39 M50 M46 M48 M38 M
Income before tax-180 M-243 M-234 M-229 M-180 M
Interest income2 M2 M
InterestExpenseNonOperating2 M13 M19 M14 M14 M
MiscOtherSpecialCharges8 M3 M2 M2 M15 M
Net income from total operations-180 M-243 M-234 M-229 M-180 M
NetIncomeCommonStockholders-180 M-243 M-234 M-229 M-180 M
NetIncomeContinuousOperations-180 M-243 M-234 M-229 M-180 M
NetNonOperatingInterestIncomeExpense-2 M-13 M-19 M12 M-12 M
Normalized income-126 M
Operating income-186 M-234 M-216 M-219 M-184 M
Operating income before depreciation (EBITDA)-177 M-226 M-209 M-211 M-162 M
OperatingExpense186 M234 M216 M219 M184 M
Other income net-8 M-3 M-2 M1 M5 M
OtherGandA39 M50 M46 M48 M38 M
OtherOperatingExpenses-2 M-2 M-2 M-65000.0-10 M
RentAndLandingFees3 M
Research & development expense147 M184 M170 M171 M135 M
ResearchExpense147 M184 M170 M171 M135 M
Selling Gen & administrative expense39 M50 M46 M48 M38 M
Total Income available for interest expense (EBIT)-178 M-231 M-215 M-215 M-166 M
Total common shares outstanding66 M76 M76 M95 M226 M
Total net income-180 M-243 M-234 M-229 M-180 M
Total ordinary shares227 M227 M227 M227 M227 M
TotalExpenses186 M234 M216 M219 M174 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University